| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |